Singapore COVID-19 study: Vitamin B12, D and magnesium supplementation reduce severity in older patients
A cohort study in Singapore found that the combination of vitamin D, magnesium and vitamin B12 (DMB) could reduce the rate of progression in older patients with Covid-19.
The study conducted by researchers at the Singapore General Hospital and Duke-NUS Medical School reported that patients who received DMB had a significant reduction of clinical deterioration compared to patients without DMB. Clinical deterioration was recognised as requiring oxygen support and intensive care support.
Researchers pointed out that many of the current therapeutic efforts were targeted at viral elimination instead of pre-emptively modulating hyper-inflammation.
They explained: “Covid-19 is a multi-organ phenomenon and it is becoming evident that appropriate systemic inflammatory control is necessary for overall survival benefit.”
